High Intensity Focused Ultrasound System For Peripheral Neural Tissue Ablation
SGN is the FDA product code for High Intensity Focused Ultrasound System For Peripheral Neural Tissue Ablation, a class II device type, regulated under 21 CFR 882.4420. FDA's definition for this code reads: "A high intensity focused ultrasound system for peripheral neural tissue ablation is a device that transmits ultrasound energy to produce thermal lesions in a defined, targeted volume of peripheral nervous tissue through acoustic coupling". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- SGN
- Device name
- High Intensity Focused Ultrasound System For Peripheral Neural Tissue Ablation
- FDA definition
- A high intensity focused ultrasound system for peripheral neural tissue ablation is a device that transmits ultrasound energy to produce thermal lesions in a defined, targeted volume of peripheral nervous tissue through acoustic coupling.
- Regulation
- 21 CFR 882.4420
- Device class
- Class II
- Review panel
- Neurology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code SGN
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2025 | 1 |
Applicants with the most clearances
Product code SGN| Applicant | Clearances |
|---|---|
| Fusmobile, Inc | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
